Envoy Medical, Inc.
COCH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $26,870 | $22,728 | $101,743 | $98,900 |
| - Cash | $5,483 | $4,218 | $183 | $1,121 |
| + Debt | $19,661 | $562 | $34,535 | $23,477 |
| Enterprise Value | $41,048 | $19,072 | $136,095 | $121,256 |
| Revenue | $225 | $316 | $237 | $310 |
| % Growth | -28.8% | 33.3% | -23.5% | – |
| Gross Profit | -$517 | -$473 | -$261 | -$459 |
| % Margin | -229.8% | -149.7% | -110.1% | -148.1% |
| EBITDA | -$19,806 | -$29,789 | -$8,631 | -$6,800 |
| % Margin | -8,802.7% | -9,426.9% | -3,641.8% | -2,193.5% |
| Net Income | -$20,795 | -$29,922 | -$15,923 | -$8,675 |
| % Margin | -9,242.2% | -9,469% | -6,718.6% | -2,798.4% |
| EPS Diluted | -1.49 | -2.54 | -1.57 | -1.05 |
| % Growth | 41.3% | -61.8% | -49.5% | – |
| Operating Cash Flow | -$17,949 | -$17,091 | -$8,805 | -$6,936 |
| Capital Expenditures | -$980 | -$153 | -$218 | -$125 |
| Free Cash Flow | -$18,929 | -$17,244 | -$9,023 | -$7,061 |